ClinicalTrials.Veeva

Menu

Effect of Vitamin E+Selenium on Kidney Function in Controlled Hypotension

T

Tehran University of Medical Sciences

Status and phase

Unknown
Phase 2

Conditions

Acute Kidney Injury

Treatments

Drug: vitamin E +Selenium

Study type

Interventional

Funder types

Other

Identifiers

NCT01554345
89-04-30-11624

Details and patient eligibility

About

The purpose of this study is to determine whether Kidney injury happens in controlled hypotension during brain operations by using Neutrophil Gelatinase Associated Lipocalin ELISA Kit and if so, does VitaminE+Selenium prevent it

Full description

NGAL(Neutrophil Gelatinase Associated Lipocalin) is a 25KD protein which bounds with Gelatinase in Neutrophil granules.It is also expressed in epithelial cells of kidney tubules.NGAL increases in ischemic and toxic injuries of kidney. During controlled hypotension in brain operations injury to the kidneys might occur . This study is designed to assess this possibility and evaluate the effect of VitaminE+Selenium on prevention of this problem

Enrollment

60 estimated patients

Sex

All

Ages

18 to 75 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • All patients who are candidate for brain surgery under controlled hypotension

Exclusion criteria

  • Positive history of renal disease
  • Positive history of diabetes mellitus, CHF, HTN, Breast cancer, fever, leukocytosis

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

Trial contacts and locations

1

Loading...

Central trial contact

Mahmoodreza Torkaman, resident

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems